Position in LFCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,956
-$2,134 QoQ
Shares Held
526
+5.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $13,612,825 across 48 Drug Manufacturers - Specialty & Generic names. LFCR ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
65,808 | $7,779,163 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
46,558 | $2,406,583 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,507 | $1,120,712 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,083 | $642,197 | |
| 5 | VTRS |
Viatris Inc
|
21,979 | $296,936 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,733 | $235,815 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
16,116 | $223,206 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
8,810 | $210,823 |
All Filings in LFCR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,956 | 526 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,090 | 500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,680 | 500 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $4,060 | 500 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||